Works matching IS 09255710 AND DT 2013 AND VI 98 AND IP 3


Results: 21
    2
    3
    4
    5
    6
    7

    Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study.

    Published in:
    International Journal of Hematology, 2013, v. 98, n. 3, p. 323, doi. 10.1007/s12185-013-1401-1
    By:
    • Katsutani, Shinya;
    • Tomiyama, Yoshiaki;
    • Kimura, Akiro;
    • Miyakawa, Yoshitaka;
    • Okamoto, Shinichiro;
    • Okoshi, Yasushi;
    • Ninomiya, Haruhiko;
    • Kosugi, Hiroshi;
    • Ishii, Kazuyoshi;
    • Ikeda, Yasuo;
    • Hattori, Toshihiro;
    • Katsura, Koichi;
    • Kanakura, Yuzuru
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.

    Published in:
    International Journal of Hematology, 2013, v. 98, n. 3, p. 337, doi. 10.1007/s12185-013-1402-0
    By:
    • Miyamoto, Toshihiro;
    • Yoshimoto, Goichi;
    • Kamimura, Tomohiko;
    • Muta, Tsuyoshi;
    • Takashima, Shuichiro;
    • Ito, Yoshikiyo;
    • Shiratsuchi, Motoaki;
    • Choi, Ilseung;
    • Kato, Koji;
    • Takenaka, Katsuto;
    • Iwasaki, Hiromi;
    • Takamatsu, Yasushi;
    • Teshima, Takanori;
    • Akashi, Koichi
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20